StockNews.com Begins Coverage on Mirati Therapeutics (NASDAQ:MRTX)

StockNews.com assumed coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a research note published on Sunday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Several other analysts also recently weighed in on MRTX. Leerink Partnrs downgraded Mirati Therapeutics from an outperform rating to a market perform rating in […]

Related Keywords

United States ,Leerink Partnrs ,Benjamin Hickey ,Jamie Christensen ,Stifel Nicolaus ,Scotiabank ,Acadian Asset Management ,Mirati Therapeutics Inc ,Nasdaq ,Bluepath Capital Management ,First Horizon Advisors Inc ,Quent Capital ,Mirati Therapeutics ,Free Report ,Get Free Report ,Horizon Advisors ,Asset Management ,Mirati Therapeutics Daily ,Nasdaq Mrtx ,Mrtx ,Medical ,Initiated Coverage ,Stocknews Com ,